feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Coca-Cola faces plastic criticism

trending

LeBron James faces 76ers

trending

Caitlin Clark declined overseas offer

trending

Taylor Swift at Texans game?

trending

Guilford County schools early dismissal

trending

Golden Globes nominations unveiled December

trending

Walmart Lexington bomb threat

trending

Todd Combs joins JPMorgan

trending

IBM nears Confluent acquisition

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Boy's unsteady walk reveals rare brain cancer

Boy's unsteady walk reveals rare brain cancer

19 Nov

•

Summary

  • A four-year-old boy's unsteady walking led to a brain cancer diagnosis.
  • His mother was diagnosed with breast cancer while he underwent treatment.
  • Family seeks US trial for preventative treatment not available in UK.
Boy's unsteady walk reveals rare brain cancer

A four-year-old boy named Raffi Starkowitz experienced an alarming change in his coordination, leading to an emergency hospital visit. Doctors discovered a mass on his brain, subsequently diagnosed as aggressive anaplastic medulloblastoma. Raffi underwent extensive surgery, chemotherapy, and radiotherapy. His family faced further hardship when his mother, Nicky, was diagnosed with stage three breast cancer during his treatment, requiring her own rigorous medical regimen.

Despite Raffi's scans showing no current disease, the risk of recurrence is high, with no preventative treatments available in the UK. This uncertainty prompted the family to seek experimental therapy abroad. Simultaneously, Nicky is undergoing chemotherapy for her breast cancer, adding immense emotional and logistical challenges for the family.

To access a clinical trial for a potential preventative drug, difluoromethylornithine (DFMO), Raffi has been accepted at a hospital in Pennsylvania, USA. The family is actively fundraising to cover the substantial costs associated with treatment, travel, and accommodation for this life-saving opportunity.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Raffi Starkowitz was diagnosed with group 3 large cell anaplastic medulloblastoma.
There are no preventative treatments available in the UK for his high-risk condition, so he is joining a US trial.
His parents are navigating Raffi's brain cancer and Nicky's breast cancer diagnosis simultaneously, seeking support and treatment options.

Read more news on

Healthside-arrowPennsylvaniaside-arrow

You may also like

Mum's 'Muscle Strain' Was Rare Cancer

7 hours ago • 4 reads

article image

Breast Cancer: UK Cases & Deaths to Skyrocket by 2050

1 day ago • 8 reads

article image

Mum with 12-month prognosis seeks German treatment

6 Dec • 12 reads

article image

Adrian Chiles: Cancer, ADD, and Liver Woes Revealed

4 Dec • 21 reads

article image

Scientists Discover Key to Cancer Resistance

26 Nov • 48 reads

article image